- Home
- SON vs INSP Comparison
SON vs INSP Comparison
Compare SON & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SON
- INSP
- Stock Information
- Founded
- SON 1899
- INSP 2007
- Country
- SON United States
- INSP United States
- Employees
- SON N/A
- INSP N/A
- Industry
- SON Containers/Packaging
- INSP Medical/Dental Instruments
- Sector
- SON Consumer Discretionary
- INSP Health Care
- Exchange
- SON Nasdaq
- INSP Nasdaq
- Market Cap
- SON 5.1B
- INSP 5.3B
- IPO Year
- SON N/A
- INSP 2018
- Fundamental
- Price
- SON $49.24
- INSP $185.09
- Analyst Decision
- SON Buy
- INSP Buy
- Analyst Count
- SON 6
- INSP 11
- Target Price
- SON $60.17
- INSP $231.64
- AVG Volume (30 Days)
- SON 759.9K
- INSP 614.6K
- Earning Date
- SON 02-12-2025
- INSP 02-10-2025
- Dividend Yield
- SON 4.25%
- INSP N/A
- EPS Growth
- SON N/A
- INSP N/A
- EPS
- SON 2.91
- INSP 1.09
- Revenue
- SON $6,572,688,000.00
- INSP $755,594,000.00
- Revenue This Year
- SON N/A
- INSP $29.96
- Revenue Next Year
- SON $16.95
- INSP $19.49
- P/E Ratio
- SON $16.79
- INSP $169.16
- Revenue Growth
- SON N/A
- INSP 32.52
- 52 Week Low
- SON $45.93
- INSP $123.00
- 52 Week High
- SON $61.73
- INSP $257.40
- Technical
- Relative Strength Index (RSI)
- SON 54.09
- INSP 47.88
- Support Level
- SON $46.89
- INSP $170.75
- Resistance Level
- SON $47.95
- INSP $216.01
- Average True Range (ATR)
- SON 0.94
- INSP 8.56
- MACD
- SON 0.20
- INSP -1.84
- Stochastic Oscillator
- SON 97.78
- INSP 34.60
About SON Sonoco Products Company
Over its 100-year-plus history, Sonoco Products has steadily assembled a diverse portfolio of industrial and consumer packaging product offerings such as flexible and rigid plastics, reels and spools, pallets, and composite cans. The company serves a variety of consumer and industrial end markets throughout North America. Sonoco has raised its dividend each year for more than 40 years.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.